(1-(4-Aminophenyl)piperidin-4-yl)methanol, 95%, 5g

tert-Butyl (R)-3-(4-iodo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 98%, 250mg

Seproxetine hydrochloride, 98%, 1g

N,N-Dimethylaniline [for Biochemical Research]>99.0%(GC)1g

(6-Bromo-4-methylpyridin-3-yl)boronic acid, 97%, 5g

(R)-1-(2-Methoxypyridin-4-yl)ethanamine dihydrochloride, 95.0%, 250mg

Phenanthrene-9,10-diamine, 95.0%, 5g

Methyl 4-chloro-1-methyl-1H-pyrrolo[3,2-c]pyridine-7-carboxylate, 95.0%, 100mg

Lithium metaborate 99.995+% 50 g

bScope BS.1153-EPLPHi for phase contrast. Triocular with HWF 10x/20 mm eyepieces and quintuple revolver E-plan Phase IOS 10/20/S40 S100x

(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 250mg

Ethyl 2-acetylheptanoate, 95.0%, 5g

Methyl 4-amino-6-chloro-5-fluoronicotinate, 98%, 250mg